GUARDION HEALTH SCIENCES INC (GHSI) Stock Price, Forecast & Analysis

NASDAQ:GHSI • US40145Q5009

3.25 USD
-0.01 (-0.31%)
At close: Oct 11, 2024
3.23 USD
-0.02 (-0.62%)
After Hours: 10/11/2024, 8:01:54 PM

GHSI Key Statistics, Chart & Performance

Key Statistics
Market Cap4.39M
Revenue(TTM)6.43M
Net Income(TTM)6.37M
Shares1.35M
Float1.33M
52 Week High18
52 Week Low3.04
Yearly DividendN/A
Dividend Yield153.85%
EPS(TTM)0.43
PE7.56
Fwd PEN/A
Earnings (Next)11-14
IPO2019-04-05
Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS IndustryGroupHousehold & Personal Products
GICS SubIndustryPersonal Care Products
GHSI short term performance overview.The bars show the price performance of GHSI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

GHSI long term performance overview.The bars show the price performance of GHSI in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 500 1K 1.5K

The current stock price of GHSI is 3.25 USD. In the past month the price decreased by -67.2%. In the past year, price decreased by -53.64%.

GUARDION HEALTH SCIENCES INC / GHSI Daily stock chart

GHSI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
GHSI Full Technical Analysis Report

GHSI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to GHSI. No worries on liquidiy or solvency for GHSI as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
GHSI Full Fundamental Analysis Report

GHSI Financial Highlights

Over the last trailing twelve months GHSI reported a non-GAAP Earnings per Share(EPS) of 0.43. The EPS increased by 154.16% compared to the year before.


Industry RankSector Rank
PM (TTM) 99.1%
ROA 41.65%
ROE 46.34%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%963.44%
Sales Q2Q%-97.39%
EPS 1Y (TTM)154.16%
Revenue 1Y (TTM)-43.45%
GHSI financials

GHSI Forecast & Estimates

7 analysts have analysed GHSI and the average price target is 40.8 USD. This implies a price increase of 1155.38% is expected in the next year compared to the current price of 3.25.

For the next year, analysts expect an EPS growth of -669.3% and a revenue growth 9.56% for GHSI


Analysts
Analysts82.86
Price Target40.8 (1155.38%)
EPS Next Y-669.3%
Revenue Next Year9.56%
GHSI Analyst EstimatesGHSI Analyst Ratings

GHSI Ownership

Ownership
Inst Owners7%
Ins Owners206.25%
Short Float %N/A
Short RatioN/A
GHSI Ownership

GHSI Competitors/Peers

The largest stocks on the US markets in the "Personal Care Products" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
EL ESTEE LAUDER COMPANIES-CL A35.1339.154B
KVUE KENVUE INC16.5935.829B
ELF ELF BEAUTY INC22.824.813B
IPAR INTERPARFUMS INC20.293.278B
COTY COTY INC-CL A5.062.209B
BRBR BELLRING BRANDS INC7.922.096B
OLPX OLAPLEX HOLDINGS INC15.791.041B
EPC EDGEWELL PERSONAL CARE CO8.661.023B
NATR NATURES SUNSHINE PRODS INC26.38470.925M
NUS NU SKIN ENTERPRISES INC - A5.83407.55M

About GHSI

Company Profile

GHSI logo image Guardion Health Sciences, Inc. engages in the business of developing and distributing clinically supported nutrition, medical foods, and dietary supplements. The company is headquartered in Houston, Texas and currently employs 9 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The firm sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. The company sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.

Company Info

GUARDION HEALTH SCIENCES INC

2925 Richmond Avenue, Suite 1200

Houston TEXAS 92128 US

CEO: Bret Scholtes

Employees: 9

GHSI Company Website

Phone: 18008735141

GUARDION HEALTH SCIENCES INC / GHSI FAQ

What does GHSI do?

Guardion Health Sciences, Inc. engages in the business of developing and distributing clinically supported nutrition, medical foods, and dietary supplements. The company is headquartered in Houston, Texas and currently employs 9 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The firm sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. The company sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.


What is the stock price of GUARDION HEALTH SCIENCES INC today?

The current stock price of GHSI is 3.25 USD. The price decreased by -0.31% in the last trading session.


Does GUARDION HEALTH SCIENCES INC pay dividends?

GUARDION HEALTH SCIENCES INC (GHSI) has a dividend yield of 153.85%. The yearly dividend amount is currently 0.


What is the ChartMill rating of GUARDION HEALTH SCIENCES INC stock?

GHSI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


When is the next dividend date for GUARDION HEALTH SCIENCES INC (GHSI)?

The next ex-dividend date for GUARDION HEALTH SCIENCES INC (GHSI) is September 24, 2024.


Can you provide the growth outlook for GUARDION HEALTH SCIENCES INC?

The Revenue of GUARDION HEALTH SCIENCES INC (GHSI) is expected to grow by 9.56% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Who owns GUARDION HEALTH SCIENCES INC?

You can find the ownership structure of GUARDION HEALTH SCIENCES INC (GHSI) on the Ownership tab.